FDA Inspection 1158875 — Royal Biologics, Inc.
The FDA completed an inspection of Royal Biologics, Inc. on November 16, 2021 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 16, 2021
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Hackensack, NJ (United States)